국립법무병원의 조현병 및 조현정동장애 입원환자에 대한 정신약물 치료 경향
Psychopharmacological Treatment Patterns in Patients with Schizophrenia and Schizoaffective Disorder in Forensic Inpatient Settings
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
The National Forensic Hospital is the only forensic psychiatric hospital in Korea. As of January 2016, the average number of patients assigned to each psychiatrist is more than 120. In this situation, the role of psychopharmacologic treatment becomes very important. To investigate the prescription patterns of major psychotropic medications (i.e., antipsychotics, mood stabilizers, and antidepressants), we reviewed the medical records of the patients diagnosed with schizophrenia and schizoaffective disorder who were admitted in January 2016. The data from 418 patients (403 with schizophrenia and 15 with schizoaffective disorder) were retrospectively collected and analyzed. The average number of major psychotropic medications prescribed for each patient during hospitalization was as follows: antipsychotics, 3.5±1.8; mood stabilizers, 0.5±0.7; and antidepressants, 0.5±0.8. The three most frequently prescribed antipsychotics were risperidone (21.7%), olanzapine (15.5%), and quetiapine (14.4%). More than half of the patients (233, 55.9%) were prescribed an antipsychotic polypharmacy regimen. This study found that patients with schizophrenia and schizoaffective disorder in forensic psychiatric hospital tend to be prescribed many psychotropic medications.
Abstract
The National Forensic Hospital is the only forensic psychiatric hospital in Korea. As of January 2016, the average number of patients assigned to each psychiatrist is more than 120. In this situation, the role of psychopharmacologic treatment becomes very important. To investigate the prescription patterns of major psychotropic medications (i.e., antipsychotics, mood stabilizers, and antidepressants), we reviewed the medical records of the patients diagnosed with schizophrenia and schizoaffective disorder who were admitted in January 2016. The data from 418 patients (403 with schizophrenia and 15 with schizoaffective disorder) were retrospectively collected and analyzed. The average number of major psychotropic medications prescribed for each patient during hospitalization was as follows: antipsychotics, 3.5±1.8; mood stabilizers, 0.5±0.7; and antidepressants, 0.5±0.8. The three most frequently prescribed antipsychotics were risperidone (21.7%), olanzapine (15.5%), and quetiapine (14.4%). More than half of the patients (233, 55.9%) were prescribed an antipsychotic polypharmacy regimen. This study found that patients with schizophrenia and schizoaffective disorder in forensic psychiatric hospital tend to be prescribed many psychotropic medications.
참고문헌 (15)
- Degl' Innocenti A, "First report from the Swedish National Forensic Psychiatric Register (SNFPR)", Int J Law Psychiatry, 37, pp.231~237 (2014)
- 김원, "정신분열병 입원 환자에서의 다중약물요법: 일 대학병원에서의 1997년과 2003년의 비교", 대한정신약물학회지, 16(5), pp.390~395 (2005), 대한정신약물학회
- 황인환, "조현병 환자의 입원 치료시 약물처방 경향의 변화 : 일 대학병원에서 1996~2000년과 2006~2010년의 차이 비교", 생물정신의학, 21(2), pp.49~56 (2014), 대한생물정신의학회
- Stone-Brown K, "Psychotropic prescribing in seriously violent men with schizophrenia or personality disorder in a UK high security hospital", CNS Spectr, 21, pp.60~69 (2016)
- Paton C, "Patterns of antipsychotic and anticholinergic prescribing for hospital inpatients", J Psychopharmacol, 17, pp.223~229 (2003)
- British Medical Association; Royal Pharmaceutical Society of Great Britain., "British National Formulary" (2015), BMJ Books &Pharmaceutical Press
- Whicher E, "'As required' medication regimens for seriously mentally ill people in hospital", Cochrane Database Syst Rev, (2), pp.CD003441~ (2002)
- 장진구, "조현병 환자에서 항정신병약물 병용요법의 최근 동향", 대한정신약물학회지, 24(4), pp.137~146 (2013), 대한정신약물학회
- Korean Medication Algortihm Project for Schizophrenia., "The guideline of Korean medication algorithm for schizophrenia patients", Committee for KMAP, ~ (2006)
- American Psychiatric Association., "Practice guidelines for the treatment of patients with schizophrenia", American Psychiatric Association, ~ (2004)
- Moore TA, "The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia:2006 update", J Clin Psychiatry, 68, pp.1751~1762 (2007)
- Kreyenbuhl J, "The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009", Schizophr Bull, 36, pp.94~103 (2010)
- "Psychosis and schizophrenia in adults: prevention and management (clinical guideline 178)" (2014)[URL]
- Galletly C, "Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders", Aust N Z J Psychiatry, 50, pp.410~472 (2016)
- Kane JM., "The use of depot neuroleptics: clinical experience in the United States", J Clin Psychiatry, 45(5 Pt 2), pp.5~12 (1984)